FlowView Diagnostics News

Our latest news and updates from FlowView Diagnostics. Stay up-to-date with our innovations, partnerships, and research highlights that are shaping the future of flow cytometry.

Marsha Hartman photo

Dr. Marsha Hartman, PhD

Read >

A single red ball among many white balls.

Press Release

EU RESOLVE project

Read >

Collaboration with IT service provider Vitas

Introducing Asudes, our upcoming software platform revolutionizing blood analysis. It automates the detection of cancer cells, viruses, bacteria, and more while prioritizing patient data security.

Automating Blood Analysis: FlowView Diagnostics' Vision

FlowView's technology automates blood analysis, eliminating manual processes. Find out how this partnership between Radboud University and Universitair Medisch Centrum Utrecht is reshaping patient outcomes.

"As an entrepreneur you have to create the opportunities yourself"

Ton van den Hoven has over 30 years in MedTech & Life Sciences. In 2023, his company FlowView Diagnostics plans to enter the market.

FlowView Diagnostics news! We raised €875,000 for further development.

FlowView Diagnostics from Heerenveen receives an investment of 875,000 euros from a consortium of investors, including the NOM and the Steppingstone Fund.

70 Top Health Diagnostics Startups and Companies in The Netherlands (2021)

FlowView Diagnostics is honored to be among the top health diagnostics startups in The Netherlands for 2021. Our AI-driven solutions are revolutionizing diagnostics, with a focus on cancer cell detection and infectious disease analysis.